Research Reports
Every report we've published, newest first.
RCT Rockets 114% on Saudi Deal but Dilution Machine Keeps Grinding
Apr 13, 2026RCT exploded 114% pre-market on a Saudi licensing deal, but the celebration masks a deeper story of chronic dilution and unsustainable cash burn that licensing agreements won't fix.
Read → RMSGRMSG: The Tape Tells a Different Story Than the Headlines
Apr 13, 2026RMSG just doubled overnight on massive volume while everyone focuses on Nasdaq compliance issues. The tape suggests smart money sees opportunity in the distress.
Read → AIXIAIXI Explodes 51% Pre-Market on Apple Patent Play — But the Delisting Clock Is Still Ticking
Apr 10, 2026AIXI rockets 51% pre-market as the Apple patent momentum trade reignites, but delisting risk, a wrecked balance sheet, and micro-cap mechanics make this one of the most dangerous tickers on the board.
Read → RAYARAYA Surges 107% Pre-Market on $400K Private Placement — The Micro-Cap Dilution Machine Cranks Up Again
Apr 10, 2026RAYA rockets over 100% pre-market after disclosing a $400K offshore private placement at $0.08 per share while running a $20M ATM facility — textbook small-cap volatility meets dilution mechanics.
Read → CREGCREG Up 39% Pre-Market: The Red Flags Behind Smart Powerr's Momentum
Apr 10, 2026CREG surges on no news, but the filing history reveals a dilution machine with questionable business fundamentals — here's what the documents actually show.
Read → GLMDGLMD: Brain-Penetrating Aramchol News Drives 88% Premarket Surge
Apr 9, 2026GLMD explodes 88% higher premarket after announcing breakthrough brain-penetrating formulation of Aramchol, potentially expanding from NASH treatment into massive CNS disease markets.
Read → ONCOONCO Pops 38% Pre-Market as Realbotix AI Robot Delivery Narrative Fights Dilution Reality
Apr 9, 2026ONCO jumps 38% pre-market after Realbotix delivered its first AI-equipped humanoid robot to Ericsson, but the real story is massive shareholder dilution from a pending acquisition that could give existing investors as little as 10% of the combined company.
Read → QNCXQNCX Pre-Market Surge: Distressed Biotech Rides Momentum Wave After Strategic Review
Apr 8, 2026QNCX doubles in pre-market on no fresh news, riding biotech momentum despite failed Phase 3 trials and ongoing strategic review — a high-risk momentum play with thin float dynamics.
Read → BBGIBBGI Surges 70% Pre-Market as Debt Restructuring Meets Earnings Beat
Apr 8, 2026Beasley Broadcast explodes higher on earnings day as debt restructuring progress and better-than-expected Q4 results trigger massive short squeeze.
Read → OMEXOMEX Odyssey Marine: $1B Merger Deal Powers 162% Pre-Market Surge
Apr 8, 2026OMEX rockets 162% pre-market on a $1B merger deal with American Ocean Minerals, but the required 25-for-1 reverse stock split reveals the dilution reality behind the billion-dollar headlines.
Read → IPSTIPST Erupts 61% Pre-Market: The Heritage Distillery Turned Blockchain IP Play That Nobody Saw Coming
Apr 7, 2026Heritage Distilling's complete pivot to IP Strategy Holdings caught the market flat-footed, with the stock now up 61% pre-market as traders scramble to understand the Story Protocol validator play.
Read → SILOSILO Pharma Patent Win Drives 62% Pre-Market Surge But Dilution Risk Lurks
Apr 7, 2026SILO explodes 62% on European PTSD patent approval, but its history of dilutive offerings and massive cash burn create a complex risk-reward setup for momentum traders.
Read →